Tricyclic pyrimidines as inhibitors of DYRK1A/DYRK1B as potential treatment for Down's syndrome or Alzheimer's disease

ACS Medicinal Chemistry Letters

Volumn 4, Issue 6, 2013, Pages 502-503

  Rosse, Gerard ^a,b  

^a DART NEUROSCIENCE LLC   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE; TRICYCLIC PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; DOWN SYNDROME; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; NOTE; PRIORITY JOURNAL;

EID: 84879077570     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400137s     Document Type: Note

References (0)